BMO Capital lowered the firm’s price target on Livent to $20 from $24 and keeps a Market Perform rating on the shares. The analyst cites the company’s Q3 earnings miss and reduced guidance primarily due to continued delays to the Argentine carbonate expansion and amid lower lithium prices and lower lithium multiples.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LTHM: